최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Human vaccines & immunotherapeutics, v.10 no.4, 2014년, pp.887 - 895
Monteiro, Mariana P
Obesity is one of the largest and fastest growing public health problems in the world. Last century social changes have set an obesogenic milieu that calls for micro and macro environment interventions for disease prevention, while treatment is mandatory for individuals already obese. The cornerston...
Obes Rev do Carmo I 11 9 2008 10.1111/j.1467-789X.2007.00422.x
Executive Summary. Obesity research, vol.6, no.suppl2,
Bray, George A.. Lifestyle and Pharmacological Approaches to Weight Loss: Efficacy and Safety. The Journal of clinical endocrinology & metabolism, vol.93, no.11, s81-s88.
Pi‐Sunyer, F. Xavier. The Obesity Epidemic: Pathophysiology and Consequences of Obesity. Obesity research, vol.10, no.suppl12,
Peeters, Anna, Barendregt, Jan J., Willekens, Frans, Mackenbach, Johan P., Mamun, Abdullah Al, Bonneux, Luc. Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis. Annals of internal medicine, vol.138, no.1, 24-.
Stewart, Susan T., Cutler, David M., Rosen, Allison B.. Forecasting the Effects of Obesity and Smoking on U.S. Life Expectancy. The New England journal of medicine, vol.361, no.23, 2252-2260.
Christou, Nicolas V., Sampalis, John S., Liberman, Moishe, Look, Didier, Auger, Stephane, McLean, Alexander P.H., MacLean, Lloyd D.. Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients. Annals of surgery, vol.240, no.3, 416-424.
Moayyedi, Paul. The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview. Digestive diseases and sciences, vol.53, no.9, 2293-2299.
Snow, Vincenza, Barry, Patricia, Fitterman, Nick, Qaseem, Amir, Weiss, Kevin. Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline from the American College of Physicians. Annals of internal medicine, vol.142, no.7, 525-.
Fujioka, Ken. Management of Obesity as a Chronic Disease: Nonpharmacologic, Pharmacologic, and Surgical Options. Obesity research, vol.10, no.suppl12,
Bays, Harold E. Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development. Expert review of cardiovascular therapy, vol.9, no.3, 265-277.
Bays, H.E.,, Gadde, K.M.,. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity. Drugs of today, vol.47, no.12, 903-.
J Manag Care Pharm Kelly EM 642 19 2013 10.18553/jmcp.2013.19.8.642
Rucker, Diana, Padwal, Raj, Li, Stephanie K, Curioni, Cintia, Lau, David C W. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ : British medical journal, vol.335, no.7631, 1194-1199.
Bult, Mariëlle J F, van Dalen, Thijs, Muller, Alex F. Surgical treatment of obesity. European journal of endocrinology, vol.158, no.2, 135-145.
Fisher, Barry L, Schauer, Philip. Medical and surgical options in the treatment of severe obesity. The American journal of surgery, vol.184, no.6, S9-S16.
Picot, J, Jones, J, Colquitt, JL, Gospodarevskaya, E, Loveman, E, Baxter, L, Clegg, AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health technology assessment : HTA, vol.13, no.41,
Buchwald, Henry, Williams, Stanley E.. Bariatric Surgery Worldwide 2003. Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand, vol.14, no.9, 1157-1164.
Nature Schwartz MW 661 404 2000 10.1038/35007534
Millington, George WM. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutrition & metabolism, vol.4, no.1, 18-18.
Williams, Gareth, Harrold, Joanne A., Cutler, David J.. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proceedings of the Nutrition Society, vol.59, no.3, 385-396.
Field, Benjamin C. T., Chaudhri, Owais B., Bloom, Stephen R.. Obesity treatment: novel peripheral targets. British journal of clinical pharmacology, vol.68, no.6, 830-843.
De Vriese, C., Delporte, C.. Ghrelin: A new peptide regulating growth hormone release and food intake. The international journal of biochemistry & cell biology, vol.40, no.8, 1420-1424.
Tang-Christensen, Mads, Vrang, Niels, Ortmann, Sylvia, Bidlingmaier, Martin, Horvath, Tamas L., Tschöp, Matthias. Central Administration of Ghrelin and Agouti-Related Protein (83-132) Increases Food Intake and Decreases Spontaneous Locomotor Activity in Rats. Endocrinology, vol.145, no.10, 4645-4652.
Tschöp, Matthias, Smiley, David L., Heiman, Mark L.. Ghrelin induces adiposity in rodents. Nature, vol.407, no.6806, 908-913.
Wren, Alison M., Small, Caroline J., Abbott, Caroline R., Dhillo, Waljit S., Seal, Leighton J., Cohen, Mark A., Batterham, Rachel L., Taheri, Shahrad, Stanley, Sarah A., Ghatei, Mohammad A., Bloom, Stephen R.. Ghrelin Causes Hyperphagia and Obesity in Rats. Diabetes, vol.50, no.11, 2540-2547.
Kojima, Masayasu, Hosoda, Hiroshi, Date, Yukari, Nakazato, Masamitsu, Matsuo, Hisayuki, Kangawa, Kenji. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, vol.402, no.6762, 656-660.
Cone, R D, Cowley, M A, Butler, A A, Fan, W, Marks, D L, Low, M J. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, vol.25, no.suppl5, S63-S67.
Hosoda, Hiroshi, Kojima, Masayasu, Matsuo, Hisayuki, Kangawa, Kenji. Purification and Characterization of Rat des-Gln14-Ghrelin, a Second Endogenous Ligand for the Growth Hormone Secretagogue Receptor. The Journal of biological chemistry, vol.275, no.29, 21995-22000.
Cummings, David E., Weigle, David S., Frayo, R. Scott, Breen, Patricia A., Ma, Marina K., Dellinger, E. Patchen, Purnell, Jonathan Q.. Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. The New England journal of medicine, vol.346, no.21, 1623-1630.
Stock, Sue, Leichner, Pierre, Wong, Alfred C. K., Ghatei, Mohamed A., Kieffer, Timothy J., Bloom, Stephen R., Chanoine, Jean-Pierre. Ghrelin, Peptide YY, Glucose-Dependent Insulinotropic Polypeptide, and Hunger Responses to a Mixed Meal in Anorexic, Obese, and Control Female Adolescents. The Journal of clinical endocrinology & metabolism, vol.90, no.4, 2161-2168.
Hansen, Troels Krarup, Dall, Rolf, Hosoda, Hiroshi, Kojima, Masayasu, Kangawa, Kenji, Christiansen, Jens Sandahl, Jørgensen, Jens Otto Lunde. Weight loss increases circulating levels of ghrelin in human obesity. Clinical endocrinology, vol.56, no.2, 203-206.
Janas-Kozik, M., Krupka-Matuszczyk, I., Malinowska-Kolodziej, I., Lewin-Kowalik, J.. Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa. Regulatory peptides, vol.140, no.1, 43-46.
Verhulst, P., De Smet, B., Saels, I., Thijs, T., Ver Donck, L., Moechars, D., Peeters, T.L., Depoortere, I.. Role of Ghrelin in the Relationship Between Hyperphagia and Accelerated Gastric Emptying in Diabetic Mice. Gastroenterology, vol.135, no.4, 1267-1276.
Esler, William P., Rudolph, Joachim, Claus, Thomas H., Tang, Weifeng, Barucci, Nicole, Brown, Su-Ellen, Bullock, William, Daly, Michelle, DeCarr, Lynn, Li, Yaxin, Milardo, Lucinda, Molstad, David, Zhu, Jian, Gardell, Stephen J., Livingston, James N., Sweet, Laurel J.. Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite, and Promote Weight Loss. Endocrinology, vol.148, no.11, 5175-5185.
Monteiro, Mariana P., Ribeiro, Andreia H., Nunes, Ana F., Sousa, Mónica M., Monteiro, J. Duarte, Águas, Artur P., Cardoso, M. Helena. Increase in Ghrelin Levels After Weight Loss in Obese Zucker Rats is Prevented by Gastric Banding. Obesity surgery : the official journal of the American Society for Bariatric Surgery and of the Obesity Surgery Society of Australia and New Zealand, vol.17, no.12, 1599-1607.
Bourinbaiar, A.S., Jirathitikal, V.. Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices. Vaccine, vol.28, no.15, 2763-2768.
Johansen, Thue, Malmlöf, Kjell. Treatment of Obesity Using GH. Metabolic syndrome and related disorders, vol.4, no.1, 57-69.
Haffer, Keith N. Effects of novel vaccines on weight loss in diet-induced-obese (DIO) mice. Journal of animal science and biotechnology, vol.3, 21-21.
Calanna, Salvatore, Christensen, Mikkel, Holst, Jens J., Laferrère, Blandine, Gluud, Lise L., Vilsbøll, Tina, Knop, Filip K.. Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes : Systematic review and meta-analysis of clinical studies. Diabetes care, vol.36, no.10, 3346-3352.
Yip, R G, Boylan, M O, Kieffer, T J, Wolfe, M M. Functional GIP receptors are present on adipocytes.. Endocrinology, vol.139, no.9, 4004-4007.
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., Drucker, Daniel. J.. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. The Journal of clinical investigation, vol.117, no.1, 143-152.
Gault, V. A., McClean, P. L., Cassidy, R. S., Irwin, N., Flatt, P. R.. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia, vol.50, no.8, 1752-1762.
Fulurija, Alma, Lutz, Thomas A., Sladko, Katja, Osto, Melania, Wielinga, Peter Y., Bachmann, Martin F., Saudan, Philippe. Vaccination against GIP for the Treatment of Obesity. PloS one, vol.3, no.9, e3163-.
Irwin, N., Flatt, P. R.. Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia, vol.52, no.9, 1724-1731.
Kojima, Masayasu, Kangawa, Kenji. Ghrelin: Structure and Function. Physiological reviews, vol.85, no.2, 495-522.
Wortley, Katherine E., Anderson, Keith D., Garcia, Karen, Murray, Jane D., Malinova, Lubomira, Liu, Rong, Moncrieffe, Marshena, Thabet, Karen, Cox, Hilary J., Yancopoulos, George D., Wiegand, Stanley J., Sleeman, Mark W.. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proceedings of the National Academy of Sciences of the United States of America, vol.101, no.21, 8227-8232.
Sun, Yuxiang, Wang, Pei, Zheng, Hui, Smith, Roy G.. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proceedings of the National Academy of Sciences of the United States of America, vol.101, no.13, 4679-4684.
De Smet, B., Depoortere, I., Moechars, D., Swennen, Q., Moreaux, B., Cryns, K., Tack, J., Buyse, J., Coulie, B., Peeters, T. L.. Energy Homeostasis and Gastric Emptying in Ghrelin Knockout Mice. The Journal of pharmacology and experimental therapeutics, vol.316, no.1, 431-439.
Wortley, K. E., del Rincon, J.-P., Murray, J. D., Garcia, K., Iida, K., Thorner, M. O., Sleeman, M. W.. Absence of ghrelin protects against early-onset obesity. The Journal of clinical investigation, vol.115, no.12, 3573-3578.
Zhang, Jian V., Ren, Pei-Gen, Avsian-Kretchmer, Orna, Luo, Ching-Wei, Rauch, Rami, Klein, Cynthia, Hsueh, Aaron J. W.. Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin’s Effects on Food Intake. Science, vol.310, no.5750, 996-999.
Holst, Birgitte, Cygankiewicz, Adam, Jensen, Tine Halkjær, Ankersen, Michael, Schwartz, Thue W.. High Constitutive Signaling of the Ghrelin Receptor-Identification of a Potent Inverse Agonist. Molecular endocrinology, vol.17, no.11, 2201-2210.
Pantel, J., Legendre, M., Cabrol, S., Hilal, L., Hajaji, Y., Morisset, S., Nivot, S., Vie-Luton, M.-P., Grouselle, D., de Kerdanet, M.. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. The Journal of clinical investigation, vol.116, no.3, 760-768.
Maletínská, L., Matyšková, R., Maixnerová, J., Sýkora, D., Pýchová, M., Špolcová, A., Blechová, M., Drápalová, J., Lacinová, Z., Haluzík, M., Železná, B.. The Peptidic GHS-R antagonist [D-Lys3]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity. Molecular and cellular endocrinology, vol.343, no.1, 55-62.
Shearman, Lauren P, Wang, Sheng-Ping, Helmling, Steffen, Stribling, D Sloan, Mazur, Paul, Ge, Lan, Wang, Liyang, Klussmann, Sven, Macintyre, D Euan, Howard, Andrew D, Strack, Alison M. Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice.. Endocrinology, vol.147, no.3, 1517-1526.
Kobelt, P. Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats. Gut: journal of the British Society of Gastroenterology, vol.55, no.6, 788-792.
Yang, Jing, Zhao, Tong-Jin, Goldstein, Joseph L., Brown, Michael S.. Inhibition of ghrelin O -acyltransferase (GOAT) by octanoylated pentapeptides. Proceedings of the National Academy of Sciences of the United States of America, vol.105, no.31, 10750-10755.
Mayorov, Alexander V., Amara, Neri, Chang, Jason Y., Moss, Jason A., Hixon, Mark S., Ruiz, Diana I., Meijler, Michael M., Zorrilla, Eric P., Janda, Kim D.. Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice. Proceedings of the National Academy of Sciences of the United States of America, vol.105, no.45, 17487-17492.
Barnett, Brad P., Hwang, Yousang, Taylor, Martin S., Kirchner, Henriette, Pfluger, Paul T., Bernard, Vincent, Lin, Yu-yi, Bowers, Erin M., Mukherjee, Chandrani, Song, Woo-Jin, Longo, Patti A., Leahy, Daniel J., Hussain, Mehboob A., Tschöp, Matthias H., Boeke, Jef D., Cole, Philip A.. Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor. Science, vol.330, no.6011, 1689-1692.
Nakazato, Masamitsu, Murakami, Noboru, Date, Yukari, Kojima, Masayasu, Matsuo, Hisayuki, Kangawa, Kenji, Matsukura, Shigeru. A role for ghrelin in the central regulation of feeding. Nature, vol.409, no.6817, 194-198.
Lu, Shu-Chen, Xu, Jing, Chinookoswong, Narumol, Liu, Shuying, Steavenson, Shirley, Gegg, Colin, Brankow, David, Lindberg, Richard, Véniant, Murielle, Gu, Wei. An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice. Molecular pharmacology, vol.75, no.4, 901-907.
Zakhari, JosephS., Zorrilla, Eric P., Zhou, Bin, Mayorov, Alexander V., Janda, Kim D.. Oligoclonal Antibody TargetingGhrelin Increases Energy Expenditure and Reduces Food Intake in FastedMice. Molecular pharmaceutics, vol.9, no.2, 281-289.
Vizcarra, J.A., Kirby, J.D., Kim, S.K., Galyean, M.L.. Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs. Domestic animal endocrinology, vol.33, no.2, 176-189.
Zorrilla, Eric P., Iwasaki, Shinichi, Moss, Jason A., Chang, Jason, Otsuji, Jonathan, Inoue, Koki, Meijler, Michael M., Janda, Kim D.. Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America, vol.103, no.35, 13226-13231.
Kellokoski, Eija, kummu, Outi, Serpi, Raisa, Lehenkari, Petri, ukkola, Olavi, Kesäniemi, Y. Antero, Hörkkö, Sohvi. Ghrelin vaccination decreases plasma MCP-1 level in LDLR−/−-mice. Peptides, vol.30, no.12, 2292-2300.
Noad, Rob, Roy, Polly. Virus-like particles as immunogens. Trends in microbiology, vol.11, no.9, 438-444.
Lechner, Franziska, Jegerlehner, Andrea, Tissot, Alain C., Maurer, Patrik, Sebbel, Peter, Renner, Wolfgang A., Jennings, Gary T., Bachmann, Martin F.. Virus-Like Particles as a Modular System for Novel Vaccines. Intervirology, vol.45, no.4, 212-217.
Jennings, Gary T., Bachmann, Martin F.. Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases. Annual review of pharmacology and toxicology, vol.49, 303-326.
Brown, Morris J. Therapeutic Potential of Vaccines in the Management of Hypertension :. Drugs, vol.68, no.18, 2557-2560.
Andrade, Sara, Pinho, Filipa, Ribeiro, Andreia M, Carreira, Marcos, Casanueva, Felipe F, Roy, Polly, Monteiro, Mariana P. Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment. Current pharmaceutical design, vol.19, no.36, 6551-6558.
Hewat, Elizabeth A., Booth, Timothy F., Wade, Richard H., Roy, Polly. 3-D reconstruction of bluetongue virus tubules using cryoelectron microscopy. Journal of structural biology, vol.108, no.1, 35-48.
Ghosh, M.K., Borca, M.V., Roy, Polly. Virus-Derived Tubular Structure Displaying Foreign Sequences on the Surface Elicit CD4+ Th Cell and Protective Humoral Responses. Virology, vol.302, no.2, 383-392.
MIKHAILOV, M., MONASTYRSKAYA, K., BAKKER, T., ROY, P.. A New Form of Particulate Single and Multiple Immunogen Delivery System Based on Recombinant Bluetongue Virus-Derived Tubules. Virology, vol.217, no.1, 323-331.
Kalra, S P, Dube, M G, Sahu, A, Phelps, C P, Kalra, P S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.. Proceedings of the National Academy of Sciences of the United States of America, vol.88, no.23, 10931-10935.
Carreira, M C, Crujeiras, A B, Andrade, S, Monteiro, M P, Casanueva, F F. Ghrelin as a GH-releasing factor.. Endocrine development, vol.25, 49-58.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.